Let's Talk, Singapore with Neil Humphreys and Audrey SiekBig Pharma just rewrote the rulebook in the obesity-treatment race. Pfizer has won the bidding for Metsera after a showdown with Novo Nordisk.
Dan Koh and Emaad Akhtar unpack how this US$10 billion move signals a pivot into GLP-1 drugs, why Novo walked away and what it all means for investors tracking the next trillion-dollar health-tech frontier.
In 2 playlist(s)
Let's Talk, Singapore with Neil Humphreys and Audrey Siek
Start your day with the stories shaping Singapore — and your place in it. Join Neil Humphreys and A…Social links
Recent clips
Singapore Unfiltered: Do Singaporeans care about our greenery?
29:22
Talk of the Town: How do you raise an elite athlete in Singapore?
30:33
Breakfast Bites: How much are you willing to spend on a party?
10:47